Search

Whitetail deer (Odocoi!eus virginianus) populations of several islands along the Georgia coast have appeared to be in declining health for the past 10 years. Several explanations for this phenomenon have been proposed; however, several researchers have alluded to the over-population of the species. We calculated the carrying capacity of the Skidaway Island State Park (SISP), a portion of Skidaway Island located near the coastal City of Savannah. By determining the amount of biomass produced by several habitats located within the park, and knowing the hectares of these habitats, the total amount of biomass was calculated. Using the caloric requirements of the white-tail deer found at various regions of the continental United States, we determined the sustainable carrying capacity of a healthy deer population within the park. We calculated that approximately 11.5 deer can be annually sustained on the vegetative biomass produced by the Skidaway Island State Park (SISP). [ABSTRACT FROM AUTHOR]

Objectives: To assess oncology nurses' awareness of biomarker testing and targeted therapy for ovarian cancer., Sample & Setting: 100 oncology nurses completed an online survey in June 2022., Methods & Variables: A cross-sectional survey was used to examine nurses' understanding of ovarian cancer testing and treatments, assess barriers, and identify opportunities for further education., Results: Almost all respondents believed biomarker testing and targeted therapy were very/extremely important in diagnosing and supporting treatment of patients with ovarian cancer. Nurses were very/extremely familiar with cancer antigen 125 and germline testing, but fewer reported the same familiarity with somatic testing. Most nurses were familiar with targeted therapy for ovarian cancer, but only about half were very/extremely familiar with poly(ADP-ribose) polymerase (PARP) inhibitors. Less than half felt highly knowledgeable about PARP inhibitors., Implications for Nursing: It is important that oncology nurses understand biomarker testing and targeted therapy. There is an opportunity to provide resources to nurses to help them become more comfortable with PARP inhibitors in particular.